CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to AZN

AZD2936

Phase 2
AstraZeneca PLC (AZN)

Phase 2

Development Phase

0

Upcoming Catalysts

1

Historical Events

0

Regulatory Approvals

Development History
Aug '26
AZNPhase 2
Positive

AZD2936 Phase 2 Est. Readout

AZD2936
Aug 2026~
CT.gov
Competitive Landscape
Drug Information

Target Indication

Non-Small-Cell Lung Carcinoma

Clinical Trial

NCT04995523

Last updated: 2/9/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.